InvestorBrandNetwork (IBN) logo

InvestorBrandNetwork (IBN)

The latest articles, editorials and news releases from InvestorBrandNetwork (IBN), a growing Investor Brand Platform.

RSS Feed for InvestorBrandNetwork (IBN)

New Immunotherapy Prolongs Survival of Lung Cancer Patients

October 28, 2026 — A combination of two immunotherapy drugs has significantly extended survival in patients with one of the deadliest forms of lung cancer, with trial data showing median survival nearly doubling against the current standard of care. Results from the Phase 3 study involving 563 patients were presented during a conference of the European Society for Medical Oncology in Madrid and also published simultaneously in the New England Journal of Medicine.


InvestorNewsBreaks – Nightfood Holdings Inc. (OTCQB: NGTF) Featured in AINewsWire Editorial on AI Semiconductor Manufacturing and Automation

October 28, 2026 — Nightfood Holdings (OTCQB: NGTF), operating as TechForce Robotics, was featured in an AINewsWire editorial examining growing demand for semiconductor manufacturing equipment and automated inspection technologies amid expanding artificial intelligence (“AI”) infrastructure investment. The editorial highlights Nightfood’s recent acquisition of designs, technology and expertise for automated optical inspection (“AOI”) equipment used in chip-on-wafer-on-substrate (“CoWoS”) advanced semiconductor packaging.


NetworkNewsBreaks – VolitionRx (NYSE American: VNRX) Signs LOI With Missionpharma to Explore Global Development and Commercialization of NETosis Diagnostic Test

October 28, 2026 — VolitionRx Limited (NYSE American: VNRX), a multinational epigenetics company, announced that it has signed a nonbinding letter of intent (“LOI”) with Denmark-based Missionpharma A/S to explore the development and global commercialization of its prototype lateral flow technology (“LFT”) for detecting NETosis, a process associated with inflammation. The collaboration will initially focus on evaluating the finger-prick diagnostic test for neonatal sepsis, with potential applications in low- and middle-income countries and humanitarian emergency settings.


BioMedNewsBreaks — NanoViricides (NYSE American: NNVC) Reports Progress in Phase IIA Ebola Treatment Trial of NV-387 Oral Gummies

October 27, 2026 — NanoViricides, Inc. (NYSE American: NNVC), a clinical-stage antiviral drug developer, announced that its Phase IIA clinical trial evaluating NV-387 Oral Gummies for the treatment of Ebola Bundibugyo virus disease in the Democratic Republic of Congo (“DRC”) is progressing, with advancement to Phase IIB anticipated following completion of the initial study phase.


China Publishes Draft Reforms to Renewable Energy Spot Markets

October 27, 2026 — China has proposed a significant update to its electricity spot market rules that would allow solar and wind farms to trade power alongside their co-located battery systems, a change that could reshape how renewable energy is priced and dispatched across the country’s national grid. Businesses like Frontieras North America Inc.


DHL Report Identifies Trends That Could Shape Black Friday in 2026

October 27, 2026 — A trends report published by DHL reveals key trends that are likely to determine how Black Friday pans out for retailers who are looking to capitalize on this major shopping day in 2026. The report points out key insights that could determine which businesses will benefit, or lose out, during Black Friday.


OpenAI Reveals its Agents Deactivated Their Controls During Tests

October 27, 2026 — OpenAI has disclosed two cases where AI agents using its models interfered with in-house monitoring protections while undertaking assigned programming roles. In one incident, an AI agent disabled security alerts, while another disabled a monitoring component and later gave an inaccurate account of what it had done.


Google Employees Quit in Protest Against Pentagon AI Contracts

October 27, 2026 — Several workers at Google’s artificial intelligence division, DeepMind, have decided to leave the company because they are unhappy with its growing role in United States military projects. Their resignations show a deep divide between employees who believe AI should be developed for peaceful and helpful purposes, and a company that is increasingly working with defense institutions.